Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

A genetic marker linked to a type of hair loss was found in most patients studied.

Most women with ankylosing spondylitis tested positive for HLA-B27, suggesting it's useful for diagnosis.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

Certain genes are linked to the risk of developing Alopecia Areata.

Certain genetic variants are linked to frontal fibrosing alopecia in Spanish patients.

Mercury allergy linked to specific genes may contribute to burning mouth syndrome, and silicon might play a role in maintaining healthy hair.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

HLA-DRB5 and other genes may be linked to alopecia universalis.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Alopecia areata, a common autoimmune hair loss condition, often runs in families.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Some cancer treatments can cause abnormal fine hair growth.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.